Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul 17;3(7):e003064.
doi: 10.1136/bmjopen-2013-003064. Print 2013.

Physiological variables associated with the development of acute mountain sickness at the South Pole

Michael F Harrison  1 , Paul Anderson, Andrew Miller, Kathy O'Malley, Maile Richert, Jacob Johnson, Bruce D Johnson
Affiliations

Physiological variables associated with the development of acute mountain sickness at the South Pole

Michael F Harrison et al. BMJ Open. .

Abstract

Exposure to altitudes >2500 m can result in acute mountain sickness (AMS), a mild and usually self-limiting condition. Research has attempted to identify factors associated with developing AMS without controlling important factors related to the ascent or collecting a comprehensive set of variables.

Objectives: The Antarctic Study of Altitude Physiology (ASAP) investigated variables associated with the development of AMS in adults experiencing rapid passive transport to altitude by airplane.

Design: Our prospective observational trial collected data, including personal history, anthropometrics, vital signs, blood samples and pulmonary function, at sea level and at altitude. Statistical analysis utilised independent sample t tests to investigate between-group differences (p<0.05) and a forward, step-wise binary logisitic regression analysis was performed.

Participants: Of 248 eligible ASAP participants, those who did not use acetazolamide (N=98) were included in the present analysis.

Primary outcome measures: The diagnosis of AMS using the Lake Louise Symptom Score.

Results: Analysis of participants not using acetazolamide (n=90) found 30 participants developed AMS and 60 participants did not. Estimated plasma volume decreased significantly at altitude (p=0.025) in the AMS group as compared with the No AMS group while body weight did not change (p=0.125). Serum sodium (p=0.045) and low-density lipoprotein (LDL) (p=0.049) levels were higher in the No AMS group. A logistic regression analysis emphasised the contributions of LDL and eosinophil levels in the development of AMS.

Conclusions: These results suggest that the body water regulation and inflammation are key factors in AMS development when all other factors such as the level of physical exertion during ascent, the rate and magnitude of ascent and the use of acetazolamide are controlled.

Keywords: Altitude Medicine; Occupational & Industrial Medicine; Preventive Medicine; Public Health.

PubMed Disclaimer

References

    1. Davis PR, Pattinson KTS, Mason NP, et al. High altitude illness. J R Army Med Corps 2005;151:243–9 - PubMed
    1. Luks AM, McIntosh SE, Grissom CK, et al. Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness Environ Med 2010;21:146–55 - PubMed
    1. Hackett PH, Roach RC. High-altitude illness. N Engl J Med 2001;345:107–14 - PubMed
    1. Leaf DE, Goldfarb DS. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol 2007;102:1313–22 - PubMed
    1. Roach RC, Hackett PH. Frontiers of hypoxia research: acute mountain sickness. J Exp Biol 2001;204:3161–70 - PubMed

LinkOut - more resources